Volume 44, Issue 2, Pages (October 2011)

Slides:



Advertisements
Similar presentations
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Advertisements

Volume 11, Issue 4, Pages (April 2003)
Volume 36, Issue 5, Pages (December 2009)
Volume 33, Issue 2, Pages (January 2009)
Histone Demethylase LSD2 Acts as an E3 Ubiquitin Ligase and Inhibits Cancer Cell Growth through Promoting Proteasomal Degradation of OGT  Yi Yang, Xiaotong.
DEPTOR, an mTOR Inhibitor, Is a Physiological Substrate of SCFβTrCP E3 Ubiquitin Ligase and Regulates Survival and Autophagy  Yongchao Zhao, Xiufang Xiong,
Volume 13, Issue 4, Pages (February 2003)
Volume 38, Issue 5, Pages (June 2010)
Volume 44, Issue 4, Pages (November 2011)
Yu-Hsin Chiu, Jennifer Y. Lee, Lewis C. Cantley  Molecular Cell 
Volume 16, Issue 1, Pages (October 2004)
Volume 22, Issue 5, Pages (May 2012)
Volume 44, Issue 3, Pages (November 2011)
A Mechanism for Inhibiting the SUMO Pathway
UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes  Eun Young Seo, Seon-Pil Jin, Kyung-Cheol Sohn, Chi-Hyun Park, Dong.
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Volume 27, Issue 3, Pages (August 2007)
APCFZR1 promotes BRAF ubiquitination in a D-box–dependent manner.
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Gad Asher, Zippi Bercovich, Peter Tsvetkov, Yosef Shaul, Chaim Kahana 
Volume 68, Issue 2, Pages e6 (October 2017)
TopBP1 Controls BLM Protein Level to Maintain Genome Stability
Volume 56, Issue 1, Pages (October 2014)
Volume 38, Issue 5, Pages (June 2010)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 29, Issue 3, Pages (February 2008)
Volume 29, Issue 4, Pages (February 2008)
Volume 1, Issue 5, Pages (May 2012)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Volume 13, Issue 1, Pages (January 2008)
TNF-Induced Activation of the Nox1 NADPH Oxidase and Its Role in the Induction of Necrotic Cell Death  You-Sun Kim, Michael J. Morgan, Swati Choksi, Zheng-gang.
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Positive or Negative Roles of Different Cyclin-Dependent Kinase Pho85-Cyclin Complexes Orchestrate Induction of Autophagy in Saccharomyces cerevisiae 
Volume 38, Issue 1, Pages (April 2010)
GSK-3-Mediated Phosphorylation Enhances Maf-Transforming Activity
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Terunao Takahara, Tatsuya Maeda  Molecular Cell 
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Volume 4, Issue 4, Pages (August 2013)
Volume 59, Issue 6, Pages (September 2015)
Volume 20, Issue 4, Pages (November 2005)
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Volume 26, Issue 6, Pages (June 2007)
Rsk1 mediates a MEK–MAP kinase cell survival signal
Volume 21, Issue 6, Pages (November 2017)
Volume 18, Issue 2, Pages (August 2010)
Volume 25, Issue 5, Pages (March 2007)
Amanda O'Donnell, Shen-Hsi Yang, Andrew D. Sharrocks  Molecular Cell 
Volume 18, Issue 5, Pages (May 2005)
Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage  Dan Levy, Yaarit Adamovich,
Volume 49, Issue 6, Pages (March 2013)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Fan Yang, Huafeng Zhang, Yide Mei, Mian Wu  Molecular Cell 
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Volume 68, Issue 2, Pages e4 (October 2017)
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Dong Zhang, Kathrin Zaugg, Tak W. Mak, Stephen J. Elledge  Cell 
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
by Jianping Guo, Abhishek A
Volume 16, Issue 5, Pages (May 2009)
Yuki Okuda-Shimizu, Linda M. Hendershot  Molecular Cell 
Volume 57, Issue 2, Pages (January 2015)
Volume 22, Issue 3, Pages (May 2006)
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Volume 31, Issue 5, Pages (September 2008)
Volume 58, Issue 3, Pages (May 2015)
Presentation transcript:

Volume 44, Issue 2, Pages 290-303 (October 2011) mTOR Drives Its Own Activation via SCFβTrCP-Dependent Degradation of the mTOR Inhibitor DEPTOR  Daming Gao, Hiroyuki Inuzuka, Meng-Kwang Marcus Tan, Hidefumi Fukushima, Jason W. Locasale, Pengda Liu, Lixin Wan, Bo Zhai, Y. Rebecca Chin, Shavali Shaik, Costas A. Lyssiotis, Steven P. Gygi, Alex Toker, Lewis C. Cantley, John M. Asara, J. Wade Harper, Wenyi Wei  Molecular Cell  Volume 44, Issue 2, Pages 290-303 (October 2011) DOI: 10.1016/j.molcel.2011.08.030 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Identification of βTrCP as a DEPTOR-Interacting Protein (A and B) Immunoblot (IB) analysis of whole cell lysates derived from T98G cells that were serum-starved for 72 hr and then collected at the indicated time periods following serum readdition. Where indicated, MG132 was added to block the activity of 26S proteasome. (C) Schematic illustration of the recovered DEPTOR-associated proteins. TSCs, total spectral counts. (D) Normalized total spectral counts for βTrCP-associated proteins identified in the presence or absence of bortezomib using CompPASS (Sowa et al., 2009; Behrends et al., 2010). In addition to DEPTOR, several known βTrCP substrates were identified, as well as the USP47 binding protein. (E) Immunoblot analysis of WCL and anti-DEPTOR immunoprecipitates (IP) derived from HeLa cells. Mouse IgG was used as a negative control for the IP process. Cells were pretreated with 15 μM MG132 for 10 hr to block the proteasome pathway before harvest. (F) Immunoblot analysis of whole cell lysates and immunoprecipitates derived from HeLa cells transfected with HA-DEPTOR and the indicated FLAG-βTrCP1 constructs. Thirty hours posttransfection, cells were pretreated with 15 μM MG132 for 10 hr to block the proteasome pathway before harvest. (See also Figure S1). Molecular Cell 2011 44, 290-303DOI: (10.1016/j.molcel.2011.08.030) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 SCFβTrCP Controls DEPTOR Abundance (A) Immunoblot (IB) analysis of whole cell lysates derived from HeLa cells transfected with the indicated siRNA oligos. E2F1 scramble siRNA (SCRAMBLE) was used as a negative control. (B–D) Immunoblot analysis of whole cell lysates derived from T98G cells infected with the indicated lentiviral shRNA vectors. The infected cells were selected by 2 μg/ml puromycin for 48 hr before harvesting for immunoblot analysis. (E) Immunoblot analysis of whole cell lysates derived from HeLa cells infected with the indicated lentiviral shRNA vectors. The infected cells were selected by 1 μg/ml puromycin and 200 μg/ml hygromycin for 48 hr before harvesting for immunoblot analysis. (F) Immunoblot analysis of whole cell lysates derived from HeLa cells infected with the indicated lentiviral shRNA vectors. The infected cells were selected by 2 μg/ml puromycin for 48 hr before harvesting for immunoblot analysis. (See also Figure S2). Molecular Cell 2011 44, 290-303DOI: (10.1016/j.molcel.2011.08.030) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 SCFβTrCP Governs mTOR Signaling by Controlling DEPTOR Degradation (A) HeLa cells were infected with the indicated lentiviral shRNA constructs for 24 hr. Uninfected cells were eliminated by selection with 2 μg/ml puromycin for 48 hr. The resulting cell lines were then serum-starved for 24 hr and 10% FBS was added to the serum-starved cells for the indicated time period before harvesting. Equal amounts of whole cell lysates were immunoblotted with the indicated antibodies. (B) Quantification of the band intensities in (A). DEPTOR bands were normalized to TUBULIN, then normalized to the t = 0 time point. (C) T98G cells were infected with the indicated lentiviral shRNA constructs for 24 hr. Uninfected cells were eliminated by selection with 2 μg/ml puromycin for 48 hr. The resulting cell lines were serum-starved for 72 hr and 10% FBS was added to the serum-starved cells for the indicated time period before harvesting. Equal amounts of whole cell lysates were immunoblotted with the indicated antibodies. (D) HeLa cells were infected with the indicated lentiviral shRNA constructs for 24 hr. Noninfected cells were eliminated by selection with 2 μg/ml puromycin for 48 hr. The resulting cell lines were serum-starved for 24 hr and 10% FBS together with 20 μg/ml cycloheximide (CHX) was added to the serum-starved cells for the indicated time period before harvesting. Equal amounts of whole cell lysates were immunoblotted with the indicated antibodies. (E) Quantification of the band intensities in (D). DEPTOR bands were normalized to VINCULIN, then normalized to the t = 0 time point. (F–H) Real-time RT-PCR analysis to examine the relative DEPTOR (F), βTrCP1 (G) and βTrCP2 (H) mRNA levels in HeLa cells infected with the indicated shRNA lentiviral vectors. Three independent sets of experiments were performed to generate the error bars. The error bars represent means ± SD. Molecular Cell 2011 44, 290-303DOI: (10.1016/j.molcel.2011.08.030) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 DEPTOR Stability Is Negatively Regulated by the mTOR Signaling Pathway (A and B) Immunoblot (IB) analysis of whole cell lysates derived from T98G cells that were serum-starved for 72 hr and then collected at 16 hr following serum readdition. Where indicated, proteasome inhibitor MG132 and the indicated kinase inhibitors were added together with serum. DMSO was used as a negative control. (C) Immunoblot analysis of whole cell lysates derived from HeLa cells infected with the indicated lentiviral shRNA vectors. The infected cells were selected by 2 μg/ml puromycin for 48 hr before harvesting for immunoblot analysis. (D) HeLa cells were infected with the lentiviral shTSC2 construct (with shGFP as a negative control) for 24 hr. Noninfected cells were eliminated by selection with 2 μg/ml puromycin for 48 hr. The resulting cell lines were serum-starved for 24 hr and 10% FBS, together with the indicated kinase inhibitors, were added to the serum-starved cells for 16 hr before harvesting. DMSO was used as a negative control. Equal amounts of whole cell lysates were immunoblotted with the indicated antibodies. (E) Immunoblot analysis of whole cell lysates (WCL) and immunoprecipitates (IP) derived from HeLa cells transfected with FLAG-βTrCP1 and HA-DEPTOR constructs. Thirty hours posttransfection, cells were pretreated with 15 μM MG132 for 10 hr to block the proteasome pathway before harvest. Where indicated, cells were treated with the indicated kinase inhibitors as well for 10 hr before harvest. (See also Figure S3). Molecular Cell 2011 44, 290-303DOI: (10.1016/j.molcel.2011.08.030) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 5 Casein Kinase I Controls DEPTOR Stability (A) Immunoblot (IB) analysis of whole cell lysates derived from HeLa cells treated with the indicated CKI inhibitor (50 μM D4476 and 50 μM IC261 for 12 hr). (B) Immunoblot analysis of whole cell lysates derived from HeLa cells infected with the indicated lentiviral shRNA vectors. The infected cells were selected by 2 μg/ml puromycin for 48 hr before harvesting for immunoblot analysis. (C) Immunoblot analysis of whole cell lysates (WCL) and immunoprecipitates (IP) derived from HeLa cells transfected with FLAG-βTrCP1, GST-CKI and the indicated HA-DEPTOR constructs. Thirty hours posttransfection, cells were pretreated with 15 μM MG132 for 10 hr to block the proteasome pathway before harvest. Where indicated, PP242 or rapamycin was also added for 10 hr to inactivate mTOR kinase before harvest. Molecular Cell 2011 44, 290-303DOI: (10.1016/j.molcel.2011.08.030) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 6 mTOR-Dependent Phosphorylation of DEPTOR Triggers Its Recognition by βTrCP and Promotes DEPTOR Turnover (A and B) Schematic representation of the candidate phospho-degron in DEPTOR and the previously reported 13A DEPTOR mutant (Peterson et al., 2009). (C) Immunoblot (IB) analysis of whole cell lysates (WCL) and immunoprecipitates (IP) derived from HeLa cells transfected with FLAG-βTrCP1 and the indicated HA-DEPTOR constructs. Thirty hours posttransfection, cells were pretreated with 15 μM MG132 for 10 hr to block the proteasome pathway before harvest. (D) Immunoblot analysis of whole cell lysates derived from HeLa cells that were transfected with the indicated HA-DEPTOR constructs, and serum-starved for 24 hr before being collected at the indicated time period following serum readdition. (E) Immunoblot analysis of whole cell lysates and immunoprecipitates derived from HeLa cells transfected with FLAG-βTrCP1, GST-CKI and the indicated HA-DEPTOR constructs. Thirty hours posttransfection, cells were pretreated with 15 μM MG132 for 10 hr to block the proteasome pathway before harvest. (F) Immunoblot analysis of whole cell lysates and immunoprecipitates derived from HeLa cells transfected with FLAG-βTrCP1 and the indicated HA-DEPTOR constructs. Thirty hours posttransfection, cells were pretreated with 15 μM MG132 for 10 hr to block the proteasome pathway before harvest. (G) Autoradiograms showing the recovery of various 35S-labeled DEPTOR mutant proteins bound to GST- βTrCP1 (with GST as a negative control) after incubation with mTOR catalytic domain. (H) Immunoblot analysis of whole cell lysates derived from HeLa cells that were transfected with the indicated HA-DEPTOR constructs, and serum-starved for 24 hr before being collected at the indicated time period following serum readdition. (I) Immunoblot analysis of whole cell lysates and immunoprecipitates derived from HeLa cells transfected with FLAG-βTrCP1, GST-CKI and the indicated HA-DEPTOR constructs. Thirty hours posttransfection, cells were pretreated with 15 μM MG132 for 10 hr to block the proteasome pathway before harvest. (J) In the first step of kinase assay (labeled as 1st), purified GST-DEPTOR was incubated with mTOR (or kinase reaction buffer as a negative control) in the presence of cold ATP for 30 min. In the second step of kinase reaction (labeled as 2nd), the reaction product from the first step was further incubated with CKI kinase and γ-32P-ATP for 30 min. To eliminate mTOR activity in the second step kinase reaction, where indicated, mTOR inhibitor PP242 (0.2 μM) was added to the reaction. The kinase reaction products were separated by SDS-PAGE, and phosphorylation was detected by autoradiography. (See also Figure S4). Molecular Cell 2011 44, 290-303DOI: (10.1016/j.molcel.2011.08.030) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 7 SCFβTrCP-Mediated DEPTOR Destruction Participates In the Regulation of Cell Growth and Autophagy through Modulating the Activity of the mTOR Signaling Pathway (A) HeLa cells were transfected with wild-type DEPTOR and 3A DEPTOR mutant, along with empty vector (EV) as a control, cells were synchronized by serum deprivation (24h), and restimulated with serum to enter the cell cycle. Cells were harvested at various times and blotted for the indicated proteins or modifications. (B) HeLa cells were infected with the indicated lentiviral shRNA constructs for 24 hr. Noninfected cells were eliminated by selection with 2 μg/ml puromycin for 48 hr. The resulting cell lines were grown in the indicated experimental conditions for 24 hr before harvesting. Equal amounts of whole cell lysates were immunoblotted with the indicated antibodies. (C) Immunoblot analysis of whole cell lysates (WCL) derived from the engineered Tet-inducible 3A DEPTOR-expressing HeLa cells (with Tet-EV as a negative control) that were incubated in serum-free medium for 12 hr to induce autophagy. Where indicated, various dose of doxycycline was used to induce the expression of 3A DEPTOR. (D) HeLa cells were infected with Hygro-pLKO-shDEPTOR (or hygro-pLKO-EV as a negative control) and then selected with 200 μg/ml Hygromycin for 72 hr to eliminate the noninfected cells. The resulting cell lines were then infected with pBabe-Puro-mCherry-GFP-LC3B retroviral construct and selected with 1 μg/ml puromycin for 48 hr to eliminate the noninfected cells before plating the resulting cells in either regular medium or glucose deprivation medium for 24 hr for confocal microscopy analysis. Scale bars, 10 μm. (E) Quantification of the average percentage of the red-only fluorescent puncta, which represents the matured antophagosome shown in (D). For each experimental condition, more than 25 cells with over 800 puncta in total were counted to generate each data point. The error bars represent means ± SD. (F) Immunoblot analysis of whole cell lysates derived from T98G cells infected with the indicated lentiviral shRNA vectors. The infected cells were selected by 200 μg/ml huygromycin for 72 hr before harvesting for immunoblot analysis. (G) Proposed model for the ubiquitination and destruction of DEPTOR by SCFβTrCP in an mTOR and CKI-dependent manner. (See also Figure S5). Molecular Cell 2011 44, 290-303DOI: (10.1016/j.molcel.2011.08.030) Copyright © 2011 Elsevier Inc. Terms and Conditions